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A step test to assess exercise-related
oxygen desaturation in interstitial lung
disease
S. Dal Corso, S.R. Duarte, J.A. Neder, C. Malaguti, M.B. de Fuccio,
C.A. de Castro Pereira and L.E. Nery
ABSTRACT: A 6-min step test (6MST) may constitute a practical method for routinely assessing
effort tolerance and exercise-related oxyhaemoglobin desaturation (ERD) in the primary care of
patients with interstitial lung disease.
In total, 31 patients (19 males) with idiopathic pulmonary fibrosis (n525) and chronic
hypersensitivity pneumonia were submitted, on different days, to two 6MSTs. Physiological
responses were compared with those found on maximal and submaximal cycle ergometer tests at
the same oxygen uptake (V9O2). Chronic breathlessness was also determined, as measured by the
baseline dyspnoea index (BDI).
Responses to 6MST were highly reproducible: 1.3¡2.0 steps?min-1, ¡5 beats?min-1 (cardiac
frequency), ¡50 mL?min-1 (V9O2), ¡7 L?min
-1 (minute ventilation) and ¡2% (arterial oxygen
saturation measured by pulse oximetry (Sp,O2)). The number of steps climbed in 6 min was
correlated to peak V9O2 and the BDI. There were significant associations among the tests in
relation to presence (change in Sp,O2 between rest and exercise o4%) and severity (Sp,O2 ,88%)
of ERD. Four patients, however, presented ERD only in response to 6MST. Resting diffusing
capacity of the lung for carbon monoxide and alveolar–arterial oxygen tension difference were the
independent predictors of the number of steps climbed.
A single-stage, self-paced 6-min step test provided reliable and reproducible estimates of exercise
capacity and exercise-related oxyhaemoglobin desaturation in interstitial lung disease patients.
KEYWORDS: Exercise induced, exercise tests, interstitial lung diseases, oxygen saturation,
oxygen uptake, pulmonary dysfunction
I
mpaired gas exchange, especially during
exertion, is a hallmark of advanced interstitial
lung disease (ILD) [1, 2]. Functional measure-
ments at rest may not be precise in determining
the presence and extent of exercise-related
oxyhaemoglobin desaturation (ERD) in the
patient population [3].
Stepping was first used as a modality of exercise
evaluation in the early 1940s [4]. Over the past
few decades, step tests have been shown to be
clinically useful in estimating exercise tolerance
[5], in evaluating the risk of post-operative
complications [6] and in assessing effort-related
hypoxaemia in different disease states [7]. For
this latter purpose, stepping is particularly
attractive since it requires a minimum of space
and technical expertise, especially if used in
association with pulse oximetry [7]. In addition,
a higher metabolic demand has been found
during step tests as compared with other ‘‘field’’
tests in chronic obstructive pulmonary disease
(COPD) and cystic fibrosis, but with a similar fall
in arterial oxygen saturation [8–10]. No previous
study, however, has prospectively investigated
the clinical role of a step test in evaluating ERD
and exercise tolerance in ILD.
Therefore, the aim of the present study was to
determine whether a single-stage, self-paced, 6-
min step test (6MST) provides reliable and
reproducible estimates of ERD and exercise
capacity in patients with fibrotic ILD. The
ultimate goal was to develop an inexpensive
and portable test that could be easily used in
primary-care settings as part of the routine
medical evaluation of the patient population.
METHODS AND MATERIALS
Subjects
For participation in the present study, subjects (n5
45) were initially recruited from the ILD outpatient
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clinic of the hospital. Clinical and functional stability was
confirmed by the absence of change in medication dosage and
forced vital capacity (FVC) values (¡5%) in the preceding
3 months. Inclusion criteria were as follows: 1) presence of
diffuse interstitial infiltrate on high-resolution computed tomo-
graphy with evidence of pulmonary fibrosis; 2) forced expiratory
volume in one second/FVC.70% with reduced FVC (below the
lower limit of normality) and/or decreased single-breath
diffusing capacity of the lung for carbon monoxide (DL,CO);
and 3) resting arterial oxygen saturation measured by pulse
oximetry (Sp,O2; Biox 3740; Ohmeda, Boulder, CO, USA) o90%
in room air. None of the subjects were receiving long-term
oxygen therapy.
During the study, 14 patients were excluded due to respiratory
infections or exacerbation of the underlying disease. The final
sample comprised 31 patients (19 males, aged 34–79 yrs), 25
with idiopathic pulmonary fibrosis (IPF) and six with biopsy-
proven chronic hypersensitivity pneumonia. A total of 14
(56%) patients with IPF underwent open lung biopsy and
presented with the pattern of usual interstitial pneumonia.
Diagnosis of IPF in the remaining patients was performed
according to the clinical criteria suggested by the American
Thoracic Society (ATS)/European Respiratory Society [11]. All
subjects gave written informed consent, which was previously
approved by the institutional medical ethics committee.
Study design
All patients initially rated their level of chronic breathlessness
(baseline dyspnoea index (BDI)) [12] and underwent ramp-
incremental cycle ergometer cardiopulmonary exercise testing
(CPETmax). After a resting period (1 h), patients performed a
6MST with metabolic and ventilatory measurements. On
another day (48 h apart), patients underwent a constant
work-rate (WR) test (CPETsubmax) at the same metabolic stress,
i.e. at the same pulmonary oxygen uptake (V9O2), of the 6MST.
After 1 h, the 6MST was repeated.
Measurements
Pulmonary function tests
Spirometric tests without bronchodilators were performed on
the CPF-System (Medical Graphics Corporation, St Paul, MN,
USA). Static lung volumes were determined by breath-by-
breath open-circuit nitrogen washout (PF-DX System; Medical
Graphics Corporation). DL,CO was measured by the modified
Krogh technique (PF-DX System; Medical Graphics
Corporation). Absolute values were compared with theoretical
values for the adult Brazilian population [13–15]. Arterial
blood samples were obtained from radial artery puncture in
standard anaerobic conditions (ABL 330; Radiometer,
Copenhagen, Denmark).
Cardiopulmonary exercise testing
The exercise tests were performed in room air. They were
carried out on an electromagnetically braked cycle ergometer
(CPE 2000; Medical Graphics Corporation). The following data
were obtained breath by breath (MGC-CPX System; Medical
Graphics Corporation) and were expressed as 15-s averages:
V9O2 and pulmonary carbon dioxide production (V9CO2);
minute ventilation (V9E); tidal volume (VT); respiratory rate;
and ventilatory equivalents for oxygen and carbon dioxide
(V9E/V9O2 and V9E/V9CO2). ECG tracings and cardiac fre-
quency (fC) were recorded continuously: oxygen pulse (V9O2/
fC) was calculated. Subjects were asked to rate ‘‘shortness of
breath’’ and ‘‘leg effort’’ at exercise cessation by using the 0–10
Borg’s category-ratio scale.
A value of resting Sp,O2–lowest Sp,O2 (DSp,O2) o4% was
considered indicative of ERD [7]. Supplemental oxygen was
not administered unless Sp,O2 was ,80% and there was intense
distress or breathlessness and/or a clinical indication was
present, as judged by the accompanying laboratory physician.
If supplemental oxygen was required, the subject was
excluded as accurate V9O2 measurements were needed in the
present study.
Incremental exercise test
During the CPETmax, the WR was continuously increased in a
linear ‘‘ramp’’ pattern (5–15 W?min-1) and was individually
selected in such a way that the ramp duration was .8 and
,12 min. Peak V9O2 values were compared with those
predicted by NEDER et al. [16].
Constant WR exercise test
The CPETsubmax was performed at a previously selected WR to
achieve a similar V9O2 to the 6MST. Considering that the
metabolic cost of stationary cycle ergometry at a given
pedalling rate depends on the external power output and the
body mass actually displaced (i.e. that of the legs), leg masses
(LM) were estimated from body weight using the following
sex-specific equations [17]:
LM males in kg5(0.2316weight in kg)+6.78 (1)
LM females in kg5(0.3346weight in kg)–0.41 (2)
The WR needed to generate a given V9O2 was then estimated as
[17]:
WR5(V9O2 in mL?min
-1–(16.86LM)+75)–10.6 (3)
6-min step test
The 6MST was performed on a 20 cm-high, single-step device
with no handles. The general principles of the test were based
on the current ATS/American College of Chest Physicians
recommendations for the 6-min walking test (6MWT) [18].
Patients were instructed to walk up and down the platform as
fast as possible during a 6-min period. They were also told that
they could slow down if necessary and even make stops for
resting. Standardised encouragement was given each minute
(e.g. ‘‘you are doing well, keep going’’) using an even tone of
voice. Patients were also told every minute for how long they
still had to climb the step. Patients established their own
cadence. The number of steps?min-1 (i.e. the rate of stepping)
was recorded. The same computer-based system described in
the Cardiopulmonary exercise testing section was used to
record metabolic and ventilatory variables. Sp,O2 values were
obtained as previously described.
Data analysis
Data are presented as mean¡SD or median (range) for
variables with parametric and nonparametric distributions,
respectively. One-way ANOVA (with post hoc Bonferroni) or
Friedman’s test were used to evaluate differences among the
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tests. Pearson’s product-moment coefficients assessed linear
association. Agreement between 6MST replicates or between
test modalities was evaluated by the Bland–Altman procedure.
Chi-squared (Fisher exact) test was used to evaluate the
association between categorical data. Backward stepwise
multiple regression analysis was used to determine the resting
predictors of the number of steps climbed in the 6MST. The
probability of a type I error was set at 5% (p,0.05).
RESULTS
Sample characteristics
On average, patients presented with mild-to-moderate restric-
tive dysfunction with low DL,CO values, which were typically
proportional to the level of lung volume reduction (table 1). As
expected, peak aerobic capacity was reduced as compared
with the predicted values (peak V9O2569.9¡14.9% predicted),
with 25 out of 31 patients presenting with peak V9O2 values
below the lower limit of normality.
Reproducibility of the step tests
All patients were able to successfully complete the step tests
without complications; supplemental oxygen was not needed
in any patient. Two patients, however, showed very low levels
of Sp,O2 (slightly ,80%; fig. 1) Supplemental oxygen was not
administered as these patients did not present intense
dyspnoea and the ECG tracing was within normal limits (see
Methods and materials section). There were no significant
between-test differences on the total number of steps climbed
and the rate of climbing: mean bias¡95% confidence interval
(CI) of the differences was 1.1¡1.5 and 1.3¡2.0 steps?min-1,
respectively. Similarly, fC, V9O2, Sp,O2 and V9E did not differ
between the tests more than ¡5 beats?min-1, ¡50 mL, ¡1.5%
and ¡7 L?min-1, respectively (p.0.05).
Exercise-related desaturation
There were no significant differences among the tests in
relation to presence and severity of ERD (table 2). As shown in
figure 1, mean bias¡95% CI of the Sp,O2 differences between
6MST CPETmax and CPETsubmax were -1.8¡4.0 and
-0.3¡3.2%, respectively. In total, 25 patients had significant
ERD (DSp,O2 o4%) during the CPETmax. Of these, 24 also
presented ERD in response to the 6MST (p,0.05). Similarly, 25
out of 26 patients who presented with ERD during the
CPETsubmax showed significant desaturation in response to
stepping (p,0.05; table 3). Interestingly, however, four
patients had ERD in response to 6MST but not in the
CPETmax. Of these, three also did not desaturate in the
CPETsubmax. Similarly, although there was a significant
between-test association in relation to ERD severity, some
patients desaturated below 88% only in response to the 6MST
TABLE 1 Resting patient characteristics
Variables Values
Demographic and anthropometric
Males/females n 19/12
Age yrs 58¡11
Body mass index kg?m-2 26.2¡2.9
Clinical and smoking history
Dyspnoea
Duration months 36 (4–120)
Baseline dyspnoea index 9 (6–12)
Smoking
Ex-smokers 14 (45.2)
Pack-yrs 21.2¡10.7
Pulmonary function
Spirometry
FVC L 2.5¡0.7
FVC % pred 77.3¡18.1
FEV1 L 2.1¡0.6
FEV1 % pred 77.6¡19.0
FEV1/FVC 82.0¡6.6
Static lung volumes
TLC L 4.1¡1.1
TLC % pred 71.8¡15.8
Lung diffusing capacity
DL,CO mL?min-1?mmHg-1 14.8¡5.8
DL,CO % pred 49.8¡17.6
DL,CO/VA % pred 84.0¡20.5
Gas exchange
Pa,O2 mmHg 78.2¡9.7
PA–a,O2 mmHg 10 (1–36.5)
Sa,O2 % 95¡2
Sp,O2 % 94¡3
Data are presented as mean¡SD, median (range) or n (%), unless otherwise
stated. FVC: forced vital capacity; % pred: % predicted; FEV1: forced expiratory
volume in one second; TLC: total lung capacity; DL,CO: diffusing capacity of the
lung for carbon monoxide; VA: alveolar volume; Pa,O2: arterial oxygen tension;
PA–a,O2: alveolar–arterial oxygen tension; Sa,O2: arterial oxygen saturation; Sp,O2:
arterial oxygen saturation measured by pulse oximetry. 1 mmHg50.133 kPa.
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FIGURE 1. A Bland–Altman plot of the between-test differences on the nadir of
arterial oxygen saturation measured by pulse oximetry (Sp,O2) in patients with
interstitial lung disease. The 95% confidence intervals for the 6-min step test
submaximal cardiopulmonary exercise test differences (6MST CPETsubmax; #)
were smaller than those found for 6MST maximal CPET (CPETmax; $). ———:
mean bias¡1.96SD for 6MST CPETmax data; – – –: mean bias¡1.96SD for 6MST
CPETsubmax data.
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(table 3). There was a significant correlation between DSp,O2
with V9O2 achieved in the 6MST (r50.78; p,0.01).
Physiological responses to stepping and cycling
Stepping was associated with a near-maximum metabolic
stress as compared with CPETmax (table 2). As shown in
figure 2, mean bias¡95% CI of the between-test peak V9O2
differences was only -60¡115 mL?min-1. Importantly, the total
number of steps climbed was significantly related to both peak
V9O2 in the CPETmax and BDI (r50.52 and 0.55, respectively;
p,0.05).
No significant differences in the physiological adjustments
were found between 6MST and CPETsubmax tests (at same
V9O2; table 2). However, there was a trend for higher V9CO2/
V9O2 and V9E/V9O2 values during cycling as compared with
stepping, i.e. V9CO2 values tended to be higher at same
metabolic demand during CPETsubmax than stepping
(table 2).
Determinants of performance in the 6MST
In the present study, the physiological determinants of the
exercise capacity in the 6MST (number of steps climbed) were
also analysed. In a similar manner to other tests of functional
capacity in ILD patients [19], DL,CO (% pred) and alveolar–
arterial oxygen tension difference (PA–a,O2) were found to
account for 40% (R250.40) of the variability in this outcome
after a multiple regression analysis:
Number of steps in the 6MST5(0.596DL,CO)–
(0.886PA–a,O2 in mmHg)+90.8 (4)
DISCUSSION
The present study showed that a self-paced, single-stage 6MST
can provide reproducible and reliable estimates of the presence
and severity of pulmonary gas exchange impairment in
patients with stable, mild-to-moderate fibrotic ILD. In addi-
tion, the total number of steps climbed (and the rate of
climbing) was related to peak aerobic capacity and breath-
lessness in daily life. Therefore, the 6MST is a portable and
inexpensive method to assess the current level of functional
impairment and disability in the primary care of the patient
population.
Stepping as an ergometric modality
The present study seems to constitute the first published
investigation of the prospective validation of a step test in
patients with fibrotic ILD. It was found that between-day
reproducibility of the 6MST was very high (table 2). This was
true not only for the physiological variables but also for the
total ‘‘work’’ performed (as estimated by the number of steps
climbed) and the rate of climbing. In this context, it could be
hypothesised that, owing to the repetitive nature of the
exercise movements, the patients tended to adopt a relatively
constant rate of climbing throughout the test. Intra-individual
variability of a number of physiological variables (fC, V9O2,
Sp,O2 and V9E) were also quite low and they compare well to
those described in response to more traditional exercise tests in
these patients [19]. An important aspect was the use of a single
20-cm step: lower steps may provide insufficient metabolic
stress (i.e. the subjects would need to climb up faster,
increasing the risk of falls) [4, 5] and higher steps would
prove too difficult to climb for older subjects with knee and hip
problems.
The rationale for using a 6-min test was based on the well-
validated 6MWT. It could be speculated, however, that a
shorter test would improve patients’ compliance and test
safety. As mentioned, the rate of stepping was remarkably
constant in all patients (table 2), suggesting that a 2–3-min test
would also provide a reasonable estimate of exercise capacity
[7]. Nevertheless, it is possible that peak V9O2 was under-
estimated in these patients, especially considering ILD patients
may present with very slow V9O2 kinetics during exercise [20].
In addition, the nadir of Sp,O2 could not be reached in a test
shorter than 6 min in duration, as ERD was significantly
related to V9O2 at exercise cessation, which has been found to
increase progressively during the test (data not shown). Future
studies are therefore needed to evaluate whether shorter step
tests [7], even those using a different number of steps, are also
clinically useful in the patient population.
TABLE 2 Physiological and perceptual responses to 6-min
step test (6MST) and submaximal and maximal
cardiopulmonary exercise (CPETsubmax and
CPETmax) tests
Variables 6MST CPETsubmax CPETmax
Metabolic
V9O2 L?min
-1 0.98¡0.22 0.99¡0.21 1.09¡0.30#
V9O2 % maximal 90.6¡10.0 91.3¡9.5
V9CO2 L?min
-1 0.93¡0.23 1.07¡0.27 1.27¡0.30#
RQ 0.95¡0.06 1.06¡0.09 1.15¡0.10#
Ventilatory
V9E L?min-1 44.1¡10.2 50.0¡14.2 60.7¡14.5#
V9E/V9O2 45.7¡11.0 51.3¡14.1
" 56.9¡14.4"
V9E/V9CO2 48.6¡11.7 47.6¡12.3 49.3¡12.1
fR breaths?min-1 35¡8 37¡10 44¡11#
VT L 1.28¡0.33 1.37¡0.36 1.43¡0.39
V9E/MVV 0.46¡0.17 0.52¡0.20 0.62¡0.21#
Gas exchange
DSp,O2 % 8 (1–16) 8 (2–16) 6 (0–16)
DSp,O2/V9O2 %?L
-1 8.2 (0.7–21.6) 7.3 (1.4–21.0) 5.2 (0–20.3)+
DSp,O2 o4% 28 (90.3) 26 (83.9) 25 (80.6)
Sp,O2 ,88% 14 (45.2) 13 (41.9) 12 (38.7)
Cardiovascular
V9O2/fC mL?min
-1?beat-1 7.4¡1.8 7.4¡1.7 7.4¡1.7
fC beats?min-1 135¡14 137¡15 150¡14#
fC % pred 84.4¡8.4 85.2¡9.2 93.9¡9.1#
Symptoms
Dyspnoea score 4 (0–10) 4.5 (0–10) 7 (0–10)#
Leg effort score 4.5 (0–10) 5 (0–10) 7 (4–10)#
Data are presented as mean¡SD, median (range) or n (%). V9O2: oxygen
uptake; V9CO2: carbon dioxide production; RQ: respiratory quotient; V9E: minute
ventilation; fR: respiratory frequency; VT: tidal volume; MVV: maximum voluntary
ventilation; Sp,O2: arterial oxygen saturation measured by pulse oximetry;
DSp,O2: resting Sp,O2–lowest Sp,O2; fC: cardiac frequency. p,0.05 for
#:
CPETmax .6MST and CPETsubmax; ": CPETmax and CPETsubmax .6MST; +:
CPETmax ,6MST and CPETsubmax.
S. DAL CORSO ET AL. STEP TEST FOR INTERSTITIAL LUNG DISEASE
c
EUROPEAN RESPIRATORY JOURNAL VOLUME 29 NUMBER 2 333
Clinical implications
Abnormal gas exchange (hypoxaemia and increased alveolar–
arterial gradient) plays a central role in limiting maximal
exercise capacity in patients with ILD. In addition, ERD has
been associated with health-related quality of life [21],
pulmonary hypertension [22] and survival [23]. More recently,
ERD during field tests, such as the 6MWT and the shuttle walk
test, has been shown to be significantly related to survival in
idiopathic interstitial pneumonia [20, 24, 25].
Routine assessment of ERD by such exercise field tests in
primary-care settings, however, has been hampered by the
need for large spaces (o30-m hallway for the 6MWT), specific
equipment (an audio tape for the shuttle walking test) and
additional personnel (e.g. physiotherapists). Moreover, the
quantification of ERD during 6MWT may be unreliable in
some ILD patients [25] and the test may require an examiner to
walk with the patient to increase safety. In contrast, the 6MST
requires a portable single-stage step, which can be made
available in any medical attending room. In addition, test
monitoring is simpler and the number of steps climbed can be
easily counted. This test, therefore, may allow exercise capacity
and ERD to be determined during routine consultations to the
physician with major advantages in terms of reducing costs
and increasing the frequency of functional evaluations of ILD
patients.
Contrasting stepping versus cycling in ILD
As submaximal cycling is frequently used to assess ERD, the
present authors also compared the ventilatory and cardiovas-
cular responses at the same metabolic stress in both exercise
modalities. However, the muscle mass involved in upright
exercise is clearly larger than that in stationary cycling.
Assuming a linear relationship between muscle mass and
cardiac output, it is likely that patients needed to increase
oxygen extraction during cycling to maintain the same V9O2 of
the 6MST. Moreover, the WR per unit of muscle mass is likely
to be higher during cycling as compared to upright exercise
[26]. As a consequence, the lactate production/clearance ratio
is also higher at a given submaximal V9O2 in this exercise
modality. In fact, a trend to higher V9CO2 and respiratory
quotient was observed during cycling as compared with 6MST,
which is consistent with an earlier lactate threshold during
cycling; this was also previously found in patients with COPD
[27–29].
In this context, PALANGE et al. [27] found that ERD was more
prominent in walking than cycling and POULAIN et al. [30]
demonstrated that the 6MWT was more sensitive than cycling
to induce ERD in patients with COPD. Interestingly, this was
also the case for some of the patients in the present study,
especially when the 6MST was compared to CPETmax (table 2).
As previously mentioned, upright exercise is likely to be
TABLE 3 Association between exercise-related oxygen
desaturation in response to 6-min step test
(6MST) and submaximal and maximal
cardiopulmonary exercise (CPETsubmax and
CPETmax) tests
6MST
Yes No
DSp,O2 o4%
CPETmax
Yes 24* 1
No 4 2*
CPETsubmax
Yes 25* 1
No 3 2*
Sp,O2 ,88%
CPETmax
Yes 10* 2
No 4 15*
CPETsubmax
Yes 12* 1
No 2 16*
Data are presented as n. Sp,O2: arterial oxygen saturation measured by pulse
oximetry; DSp,O2: resting Sp,O2–lowest exercise Sp,O2. *: p,0.05 (Chi-squared
test).
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FIGURE 2. The 6-min step test (6MST) was related to a near-maximum
metabolic stress as compared with maximal cardiopulmonary exercise tests: a)
oxygen uptake (V9O2) values were close to the line of identity; and b) a Bland–
Altman analysis revealed a narrow 95% confidence interval for the between-test
differences. ———: mean bias¡1.96SD.
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associated with lower mixed venous oxygen saturation and
higher cardiac output than cycling, two factors known to
conspire against the homeostasis of intrapulmonary gas
exchange in ILD patients. In addition, upright exercise may
have a higher impact on pulmonary gas exchange inefficiency
(i.e. higher dead space volume/VT) due to differences in body
posture, lung volumes and/or central haemodynamics [27].
Study limitations
Stepping was not compared to treadmill or walking tests in the
present study; it is therefore conceivable that patients’
maximum potential for ERD was not reached. Pulse oximetry
was used to follow exercise oxygenation levels. Although this
is a clinically valid alternative, it should be recognised that
signal reliability and stability decreases markedly with read-
ings ,80% [31]. In the present study, however, only two
patients showed such low levels of Sp,O2 (fig. 1). Future studies
involving more severe patients should assess whether pulse
oximetry remains reliable during stepping exercise. It also
remains to be determined whether the test is an acceptable
strategy of exercise evaluation in more severe patients. In fact,
the present study did not include patients receiving long-term
oxygen therapy because they would be likely to need
supplemental oxygen during exercise and V9O2 was a relevant
study outcome. Additionally, further studies should be
performed to investigate whether the test is sensitive to
interventions in fibrotic ILD, such as supplemental oxygen.
Conclusions
A single-stage, self-paced 6-min step test was able to provide
reliable and reproducible estimates of exercise capacity and
oxyhaemoglobyn desaturation in patients with stable, mild-to-
moderate interstitial lung disease. The test may prove to
constitute an inexpensive and portable method for the routine
functional evaluation of the patient population in primary care.
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